Therapeutic Goods (Permissible Ingredients) Determination No. 4 of 2017

 

27 September 2017

An updated version of the Therapeutic Goods (Permissible Ingredients) Determination was registered on the Federal Register of Legislation (FRL) in September 2017. The updated determination is titled the Therapeutic Goods (Permissible Ingredients) Determination No. 4 of 2017.

 

Determination No. 4 of 2017 revokes and replaces the Therapeutic Goods (Permissible Ingredients) Determination No. 3 of 2017 which commenced in July 2017.

 

This update to the Determination has been undertaken under section 26BB of the Therapeutic Goods Act 1989 and its function remains the same.

 

A total of 287 changes have been made in the updated Determination. These changes include:

 

The addition of 6 new ingredients.

Changes to 276 existing ingredient entries, including:

making requirements for ingredients less restrictive, such as broadening the use to allow oral use when previously only for topical use;

making requirements for ingredients more restrictive, such as the inclusion of additional warning messages; and

making minor changes to make a number of entries clearer.

the removal of 5 ingredients that have been determined not to be suitable for inclusion in listed medicines.